NDC 51407-318
Theophylline(Anhydrous) 400 mg tablet, extended release
On the label: Golden State Medical Supply, Inc.. It's repackaged: Golden State Medical Supply, Inc. rebottles it from Nostrum Laboratories, Inc.'s NDC 29033-001.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Nostrum Laboratories, Inc. | Bryan, Ohio, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 13, 2025 · 6 inspections |
Repackaging site
- Golden State Medical Supply Inc., Camarillo, CA, United States · repackages it and relabels it
Recalls
- Mar 6, 2020 · Class II · Nostrum Laboratories Inc
CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
Lots: Lot: THE190501, Exp 11/2022
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Theophylline: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 400 mg
- Approval
- ANDA ANDA040560
- On the market since
- Apr 21, 2006
- Package NDCs
51407-318-01- Official label
- DailyMed (National Library of Medicine), updated May 27, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?